Right, which means they don't "legally" have the license yet. And even if they had exclusive rights to the license, it still is meaningless because it still has no clinical value assigned to it as it is still in its research phase. Hopefully it will amount to something as the Doc is one brilliant researcher. In the mean time, does Gerald even hit any of the milestones he put forth? He already whiffed on the data if you use his tweet session as a guideline.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.